1. Home
  2. LXRX vs FMNB Comparison

LXRX vs FMNB Comparison

Compare LXRX & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • FMNB
  • Stock Information
  • Founded
  • LXRX 1995
  • FMNB 1887
  • Country
  • LXRX United States
  • FMNB United States
  • Employees
  • LXRX N/A
  • FMNB N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • FMNB Major Banks
  • Sector
  • LXRX Health Care
  • FMNB Finance
  • Exchange
  • LXRX Nasdaq
  • FMNB Nasdaq
  • Market Cap
  • LXRX 552.4M
  • FMNB 555.3M
  • IPO Year
  • LXRX 2000
  • FMNB N/A
  • Fundamental
  • Price
  • LXRX $1.37
  • FMNB $13.52
  • Analyst Decision
  • LXRX Buy
  • FMNB Buy
  • Analyst Count
  • LXRX 5
  • FMNB 2
  • Target Price
  • LXRX $3.23
  • FMNB $15.50
  • AVG Volume (30 Days)
  • LXRX 2.6M
  • FMNB 146.1K
  • Earning Date
  • LXRX 11-04-2025
  • FMNB 10-22-2025
  • Dividend Yield
  • LXRX N/A
  • FMNB 5.03%
  • EPS Growth
  • LXRX N/A
  • FMNB 17.07
  • EPS
  • LXRX N/A
  • FMNB 1.44
  • Revenue
  • LXRX $58,432,000.00
  • FMNB $178,552,000.00
  • Revenue This Year
  • LXRX $66.55
  • FMNB $20.80
  • Revenue Next Year
  • LXRX N/A
  • FMNB $8.33
  • P/E Ratio
  • LXRX N/A
  • FMNB $9.39
  • Revenue Growth
  • LXRX 1504.83
  • FMNB 9.57
  • 52 Week Low
  • LXRX $0.28
  • FMNB $11.58
  • 52 Week High
  • LXRX $2.08
  • FMNB $16.29
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 48.43
  • FMNB 40.62
  • Support Level
  • LXRX $1.36
  • FMNB $13.13
  • Resistance Level
  • LXRX $1.48
  • FMNB $13.79
  • Average True Range (ATR)
  • LXRX 0.10
  • FMNB 0.40
  • MACD
  • LXRX -0.02
  • FMNB -0.04
  • Stochastic Oscillator
  • LXRX 3.33
  • FMNB 31.23

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About FMNB Farmers National Banc Corp.

Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.

Share on Social Networks: